E
ENGN//CIK 0001980845
enGene Therapeutics Inc.
Market Data
$1.84+$0.05 (+2.79%)
ENGN · Last trade
Prev Close
$1.79
Range (28d)
$1.69 – $1.95
Recent Filings
- SCHEDULE 13G/A11.9 KBenGene Therapeutics Inc.Aug 14, 5:19 PM ET·0001193125-26-352637
- SCHEDULE 13G/A17.1 KBenGene Therapeutics Inc.Aug 14, 4:49 PM ET·0001231919-26-000931
- SCHEDULE 13G/A11.5 KBenGene Therapeutics Inc.Aug 14, 8:25 AM ET·0001172661-26-003477
- SCHEDULE 13G/A18.6 KBenGene Therapeutics Inc.Aug 13, 11:40 AM ET·0002005369-26-000051
- SCHEDULE 13G/A8.1 KBenGene Therapeutics Inc.Aug 12, 4:31 PM ET·0001140361-26-032512
- 8-K11.4 MBenGene Therapeutics Inc.Aug 11, 4:03 PM ET·0001193125-26-344559
- SCHEDULE 13G12.7 KBenGene Therapeutics Inc.Jul 22, 9:14 AM ET·0001636587-26-000058
- 8-K16.6 MBenGene Therapeutics Inc.Jul 17, 4:05 PM ET·0001193125-26-307795
- 8-K234.0 KBenGene Therapeutics Inc.Jul 16, 8:06 AM ET·0001193125-26-305418
- 8-K/A203.0 KBenGene Therapeutics Inc.Jun 18, 4:06 PM ET·0001193125-26-275815
Insiders
10- Astley-Sparke PhilipDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Bos JasperDirector
- Boyd Matthew RossChief Regulatory Officer
- BRUNK GERALD ADirector
- BRYCE RICHARD PAULChief Medical Officer
- Buck JillChief Development Officer
- BVF GP HOLDINGS LLC10% Owner
- BVF I GP LLCSee Explanation of Responses
Tickers
Addresses
business
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
mailing
4868 RUE LEVY, SUITE 220
SAINT-LAURENT
Former Names
- enGene Holdings Inc.2026-03-09